Published in J Am Heart Assoc on September 23, 2014
Changes in Inflammation and Immune Activation With Atazanavir-, Raltegravir-, Darunavir-Based Initial Antiviral Therapy: ACTG 5260s. Clin Infect Dis (2015) 1.12
Utility of a novel inflammatory marker, GlycA, for assessment of rheumatoid arthritis disease activity and coronary atherosclerosis. Arthritis Res Ther (2015) 0.87
GlycA, a novel marker of inflammation, is elevated in systemic lupus erythematosus. Lupus (2015) 0.83
Circulating N-Linked Glycoprotein Acetyls and Longitudinal Mortality Risk. Circ Res (2016) 0.83
GlycA Is a Novel Biomarker of Inflammation and Subclinical Cardiovascular Disease in Psoriasis. Circ Res (2016) 0.83
GlycA, a Pro-Inflammatory Glycoprotein Biomarker, and Incident Cardiovascular Disease: Relationship with C-Reactive Protein and Renal Function. PLoS One (2015) 0.81
Circulating N-Linked Glycoprotein Side-Chain Biomarker, Rosuvastatin Therapy, and Incident Cardiovascular Disease: An Analysis From the JUPITER Trial. J Am Heart Assoc (2016) 0.81
Longitudinal Evaluation of Lipoprotein Variables in Systemic Lupus Erythematosus Reveals Adverse Changes with Disease Activity and Prednisone and More Favorable Profiles with Hydroxychloroquine Therapy. J Rheumatol (2016) 0.79
A novel inflammatory biomarker, GlycA, associates with disease activity in rheumatoid arthritis and cardio-metabolic risk in BMI-matched controls. Arthritis Res Ther (2016) 0.78
Novel Protein Glycan-Derived Markers of Systemic Inflammation and C-Reactive Protein in Relation to Glycemia, Insulin Resistance, and Insulin Secretion. Diabetes Care (2016) 0.77
sRAGE, inflammation, and risk of atrial fibrillation: results from the Atherosclerosis Risk in Communities (ARIC) Study. J Diabetes Complications (2014) 0.77
Novel measures of inflammation and insulin resistance are related to obesity and fitness in a diverse sample of 11-14 year olds: The HEALTHY Study. Int J Obes (Lond) (2016) 0.76
Association of N-Linked Glycoprotein Acetyls and Colorectal Cancer Incidence and Mortality. PLoS One (2016) 0.75
Glycosylation Signatures of Inflammation Identify Cardiovascular Risk: Some Glyc It Hot. Circ Res (2016) 0.75
Extended-Release Niacin Versus Fenofibrate in HIV-Infected Participants With Low High-Density Lipoprotein Cholesterol: Effects on Endothelial Function, Lipoproteins, and Inflammation. Clin Infect Dis (2015) 0.75
Differences in GlycA and lipoprotein particle parameters may help distinguish acute kawasaki disease from other febrile illnesses in children. BMC Pediatr (2016) 0.75
Differential Associations of Inflammatory Markers With Insulin Sensitivity and Secretion: The Prospective METSIM Study. J Clin Endocrinol Metab (2017) 0.75
Effects of statins on the immunoglobulin G glycome. Biochim Biophys Acta (2017) 0.75
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med (2000) 18.04
A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med (2005) 17.32
Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med (2002) 16.23
Glycosylation in cellular mechanisms of health and disease. Cell (2006) 8.45
Glycans in cancer and inflammation--potential for therapeutics and diagnostics. Nat Rev Drug Discov (2005) 6.14
INDIVIDUAL DIFFERENCES IN HUMAN BLOOD. Science (1931) 5.03
The impact of glycosylation on the biological function and structure of human immunoglobulins. Annu Rev Immunol (2007) 4.96
Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women. Circulation (2009) 3.93
Association of physical activity and body mass index with novel and traditional cardiovascular biomarkers in women. JAMA (2006) 2.99
Protein-glycan interactions in the control of innate and adaptive immune responses. Nat Immunol (2008) 2.77
Mammalian glycosylation in immunity. Nat Rev Immunol (2008) 2.74
Glycomics hits the big time. Cell (2010) 2.56
A systematic approach to protein glycosylation analysis: a path through the maze. Nat Chem Biol (2010) 2.30
Evaluation of the serum N-linked glycome for the diagnosis of cancer and chronic inflammation. Proteomics (2008) 1.94
Haptoglobin genotype is a consistent marker of coronary heart disease risk among individuals with elevated glycosylated hemoglobin. J Am Coll Cardiol (2013) 1.85
Glycomics: a pathway to a class of new and improved therapeutics. Nat Rev Drug Discov (2004) 1.61
Biomarker profiling by nuclear magnetic resonance spectroscopy for the prediction of all-cause mortality: an observational study of 17,345 persons. PLoS Med (2014) 1.60
Glycosylation of serum proteins in inflammatory diseases. Dis Markers (2008) 1.39
Glycosylation diseases: quo vadis? Biochim Biophys Acta (2008) 1.30
Assignment of resonances for 'acute-phase' glycoproteins in high resolution proton NMR spectra of human blood plasma. FEBS Lett (1987) 1.24
Endothelial surface N-glycans mediate monocyte adhesion and are targets for anti-inflammatory effects of peroxisome proliferator-activated receptor γ ligands. J Biol Chem (2011) 1.09
Endothelial heterogeneity and adhesion molecules N-glycosylation: implications in leukocyte trafficking in inflammation. Glycobiology (2013) 0.99
Activation of human endothelial cells by tumor necrosis factor-alpha results in profound changes in the expression of glycosylation-related genes. J Cell Physiol (2006) 0.94
Protein biomarkers of new-onset cardiovascular disease: prospective study from the systems approach to biomarker research in cardiovascular disease initiative. Arterioscler Thromb Vasc Biol (2014) 0.92
Role of endothelial N-glycan mannose residues in monocyte recruitment during atherogenesis. Arterioscler Thromb Vasc Biol (2012) 0.92
The glycan profile of endothelial cells in the present of tumor-conditioned medium and potential roles of beta-1,6-GlcNAc branching on HUVEC conformation. Mol Cell Biochem (2010) 0.87
Acute phase reactants as novel predictors of cardiovascular disease. ISRN Inflamm (2012) 0.87
Risk factors for near-term myocardial infarction in apparently healthy men and women. Clin Chem (2010) 0.84
Acute phase proteins in acute coronary syndrome: an up-to-date. Cardiovasc Hematol Agents Med Chem (2012) 0.83
Plasma haptoglobin concentrations are elevated in patients with coronary artery disease. PLoS One (2013) 0.80